Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Stockholders' Equity

v3.3.1.900
Note 10 - Stockholders' Equity
6 Months Ended
Nov. 30, 2015
Disclosure Text Block Supplement [Abstract]  
Shareholders' Equity and Share-based Payments [Text Block]
Note 10 – Stockholders’ Equity

The Company’s authorized capital stock consists of 250,000,000 shares of common stock, par value $0.0001 per share and 20,000,000 shares of preferred stock, par value $0.001 per share.    The Company had 20,070,003 and 20,000,003 shares (post Reverse Split) of common stock issued and outstanding as of November 30, 2015 and May 31, 2015, respectively.

On December 10, 2014, the Company effected a reverse stock split of the Company’s issued and outstanding common stock at a ratio of 1-for-0.625, wherein 0.625 shares of common stock were issued in exchange for each share of the Company’s common stock owned by the Company’s stockholders on December 1, 2014, the record date for the reverse stock split. As a result of the reverse stock split, 11,250,000 shares (post Reverse-Split) of common stock were outstanding as of December 10, 2014. The reverse stock split did not affect the number of authorized shares of the Company’s common stock. All share and per share information contained in the financial statements has been retroactively adjusted to reflect the reverse stock split.

The Company recorded imputed interest of $539 and $0 during the six months ended November 30, 2015 and 2014 on related party payables due to a director and officer of the Company.

On August 1, 2015, the Company and Alan Bonsett entered into a five-year employment agreement. Pursuant to the agreement, Mr. Bonsett commenced serving as the Company’s Chief Operating Officer on August 15, 2015. Mr. Bonsett is entitled to a one-time signing bonus of 250,000 (post Reverse Split) shares of restricted common stock of the Company, which will become fully vested one year from the effective date of the agreement.  As of November 30, 2015, no shares have been issued.  The Company valued the shares at $327,500 based on the stock price at August 3, 2015 and is amortizing them over the term of the employment agreement.  During the six months ended November 30, 2015, the Company recognized $109,167 in share based compensation, which is included in stock payable on the accompanying balance sheet.

Stock Issued for Services

On August 28, 2015, the Company issued 60,000 shares of common stock, valued at $45,000, to a consultant for services.  Of these shares, 50,000, valued at $37,500, were included in stock payable as of May 31, 2015.  The shares were valued based on the closing market price on the grant date.

During the six months ended November 30, 2015, pursuant to a consulting agreement, the Company issued 5,000 shares of common stock, valued at $5,750, to a consulting firm in exchange for investor relations consulting services. The consulting agreement was subsequently amended, whereby the Company issued 5,000 additional shares of common stock , valued at $6,350, and agreed to issue the consultant an additional 15,000 shares of common stock, valued at $18,050, for future consulting services. The parties are in discussions regarding whether such additional shares have been earned and it is uncertain whether these additional shares will be issued.  As of November 30, 2015, we have included 15,000 shares of common stock, valued at $18,050 in stock payable on the accompanying balance sheets.  The shares were valued based on the closing market price on the grant date.

During the six months ended November 30, 2015, pursuant to a consulting agreement, the Company agreed to issue 10,000 shares of common stock per month, valued at $11,600, to a consultant in exchange for investor relations consulting services. The consulting agreement was terminated during the first month of its term.  The parties are in discussions regarding whether any shares of the Company's common stock have been earned and it is uncertain whether any shares will be issued. As of November 30, 2015, we have included 20,000 shares of common stock, valued at $23,200 in stock payable on the accompanying balance sheets.  The shares were valued based on the closing market price on the grant date.